These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 18302652

  • 1. Bone and total alkaline phosphatase for screening skeletal metastasis in patients with solid tumours.
    Schindler F, Lajolo PP, Pinczowski H, Fonseca FL, Barbieri A, Massonetto LH, Katto FT, Del Giglio A.
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):152-6. PubMed ID: 18302652
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients.
    Tang C, Liu Y, Qin H, Li X, Guo W, Li J, Wang W, Qu L, Hu H, Xu C, Zheng L, Huang Y, Liu B, Gao H, Halleen JM, Liu X.
    Clin Chim Acta; 2013 Nov 15; 426():102-7. PubMed ID: 24055775
    [Abstract] [Full Text] [Related]

  • 3. Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen.
    Morote J, Lorente JA, Encabo G.
    Cancer; 1996 Dec 01; 78(11):2374-8. PubMed ID: 8941009
    [Abstract] [Full Text] [Related]

  • 4. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
    Ebert W, Muley T, Herb KP, Schmidt-Gayk H.
    Anticancer Res; 2004 Dec 01; 24(5B):3193-201. PubMed ID: 15510610
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of total and bone-specific alkaline phosphatase in patients with nonskeletal disorder or metabolic bone diseases.
    Woitge HW, Seibel MJ, Ziegler R.
    Clin Chem; 1996 Nov 01; 42(11):1796-804. PubMed ID: 8906079
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bone alkaline phosphatase in Paget's disease.
    Deftos LJ, Wolfert RL, Hill CS.
    Horm Metab Res; 1991 Nov 01; 23(11):559-61. PubMed ID: 1816067
    [Abstract] [Full Text] [Related]

  • 9. Comparison of bone and total alkaline phosphatase and bone mineral density in postmenopausal osteoporotic women treated with alendronate.
    Watts NB, Jenkins DK, Visor JM, Casal DC, Geusens P.
    Osteoporos Int; 2001 Nov 01; 12(4):279-88. PubMed ID: 11420777
    [Abstract] [Full Text] [Related]

  • 10. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.
    Desoize B, Veiler V, Pourny C, Comoe L, Jardillier JC.
    Anticancer Res; 1989 Nov 01; 9(4):1105-9. PubMed ID: 2817792
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of simultaneous determination of bone alkaline phosphatase mass concentration in serum and urinary excretion of pyridinium cross-links for detection of bone metastases.
    Withold W, Georgescu G, Khakzad H, Vosberg H, Mueller-Gaertner HW, Reinauer H.
    Clin Biochem; 1995 Oct 01; 28(5):511-9. PubMed ID: 8582050
    [Abstract] [Full Text] [Related]

  • 12. Comparison of bone and total alkaline phosphatase activity on bone turnover during menopause and in patients with established osteoporosis.
    Takahashi M, Kushida K, Hoshino H, Miura M, Ohishi T, Inoue T.
    Clin Endocrinol (Oxf); 1997 Aug 01; 47(2):177-83. PubMed ID: 9302392
    [Abstract] [Full Text] [Related]

  • 13. Bone alkaline phosphatase and mortality in dialysis patients.
    Drechsler C, Verduijn M, Pilz S, Krediet RT, Dekker FW, Wanner C, Ketteler M, Boeschoten EW, Brandenburg V, NECOSAD Study Group.
    Clin J Am Soc Nephrol; 2011 Jul 01; 6(7):1752-9. PubMed ID: 21597029
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Diagnosis of occult skeletal metastasis: alkaline phosphatase versus skeletal scintigraphy].
    Zieger M.
    Med Klin Prax; 1982 May 21; 77(11):44-50. PubMed ID: 7099105
    [Abstract] [Full Text] [Related]

  • 16. A reevaluation of bone scans in breast cancer.
    Hayward RB, Frazier TG.
    J Surg Oncol; 1985 Feb 21; 28(2):111-3. PubMed ID: 3918216
    [Abstract] [Full Text] [Related]

  • 17. Association of radionuclide bone scan and serum alkaline phosphatase in patients with metastatic renal cell carcinoma.
    Seaman E, Goluboff ET, Ross S, Sawczuk IS.
    Urology; 1996 Nov 21; 48(5):692-5. PubMed ID: 8911510
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancer.
    Pectasides D, Farmakis D, Nikolaou M, Kanakis I, Kostopoulou V, Papaconstantinou I, Karamanos NK, Economopoulos T, Raptis SA.
    J Pharm Biomed Anal; 2005 Feb 07; 37(1):171-6. PubMed ID: 15664758
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic value of skeletal AP and PSA with respect to skeletal scintigram in patients with prostatic disease.
    Oremek GM, Kramer W, Seiffert UB, Jonas D.
    Anticancer Res; 1997 Feb 07; 17(4B):3035-6. PubMed ID: 9329594
    [Abstract] [Full Text] [Related]

  • 20. Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer.
    Kanakis I, Nikolaou M, Pectasides D, Kiamouris C, Karamanos NK.
    J Pharm Biomed Anal; 2004 Mar 01; 34(4):827-32. PubMed ID: 15019061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.